Pemberian Agen Vasoaktif Berdasarkan Hemodinamik pada Syok Kardiogenik
Cardiogenic shock is a life-threatening emergency that occurs frequently with acutemyocardial infarction (AMI) and the mortality remains over 50% in most studies. Despitesuccessful revascularization, cardiovascular failure leading to multiple organ failure mayoccur. Therapy with vasoactive agents sh...
Main Authors: | Muhammad Yusuf Alsagaff, Laily Djihan |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Heart Association
2017-06-01
|
Series: | Majalah Kardiologi Indonesia |
Subjects: | |
Online Access: | http://ijconline.id/index.php/ijc/article/view/732 |
Similar Items
-
Cardiogenic shock - novelty and emerging therapeutic concepts
by: I. Petrov, et al.
Published: (2022-09-01) -
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
by: Jason E. Bloom, et al.
Published: (2023-08-01) -
The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
by: Rachel Ryu, et al.
Published: (2022-11-01) -
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure
by: Eduard Rodenas‐Alesina, et al.
Published: (2023-08-01) -
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial
by: Pietro Di Santo, et al.
Published: (2021-08-01)